Search results for "U.S. market"

A Milestone for K-Bio: Celltrion’s Truxima Surpasses Global Blockbuster Rituxan in U.S. Prescriptions

A Milestone for K-Bio: Celltrion’s Truxima Surpasses Global Blockbuster Rituxan in U.S. Prescriptions

Truxima , a blood cancer treatment developed by Celltrion, has become the first Korean-made biosimilar to rank number one in prescription market...
YuhanUSA and Huinno Partner to Launch AI-Powered ECG Monitoring in the U.S.

YuhanUSA and Huinno Partner to Launch AI-Powered ECG Monitoring in the U.S.

YuhanUSA, the U.S. subsidiary of Yuhan Corporation, announced on the 30th that it has signed a strategic business agreement with Huinno to spearhead...
Sam Chun Dang Pharm Secures Exclusive U.S. Licensing Deal for Oral Obesity and Diabetes Treatment

Sam Chun Dang Pharm Secures Exclusive U.S. Licensing Deal for Oral Obesity and Diabetes Treatment

Sam Chun Dang Pharm has entered into a significant license-out agreement with an undisclosed U. S.
Celltrion to Double Production Capacity with 1.2 Trillion Won Investment

Celltrion to Double Production Capacity with 1.2 Trillion Won Investment

Celltrion has announced a massive expansion across three of its major facilities in South Korea and the United States,...
A “Same-Day Surgery” Patient-Centered Hospital That Sticks to Its Principles

A “Same-Day Surgery” Patient-Centered Hospital That Sticks to Its Principles

“For our baby’s hernia surgery, we decided to go to the most well-known hospital because it involves such a precious...
Celltrion Secures Canadian Approval for ‘Steqeyma’ Autoinjector Formulation

Celltrion Secures Canadian Approval for ‘Steqeyma’ Autoinjector Formulation

Celltrion announced on March 20, 2026, that it has received additional approval from Health Canada for the autoinjector...
Kyungbo Pharmaceutical Passes U.S. FDA On-Site Inspection at Asan Plant

Kyungbo Pharmaceutical Passes U.S. FDA On-Site Inspection at Asan Plant

Kyungbo Pharmaceutical announced on the 18th that it passed an on-site manufacturing inspection by the U. S.
Alteogen Secures U.S. Patent Registration for Keytruda SC Formulation

Alteogen Secures U.S. Patent Registration for Keytruda SC Formulation

Alteogen announced on the 12th that it has secured registration with the United States Patent and Trademark Office for...
Vitamin C: Why the Secret to Health is in the Forest, Not the Pill

Vitamin C: Why the Secret to Health is in the Forest, Not the Pill

To truly understand an object, we often look at its components. By breaking a whole into small pieces to analyze their...
Daewoong Pharmaceutical: Record

Daewoong Pharmaceutical: Record "Nabota" Sales Clouded by Looming Legal Risks

As Daewoong Pharmaceutical celebrates record-breaking financial results driven by its flagship botulinum toxin, Nabota,...